These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 30974178)
1. Determination of the optimal method for the concentration and purification of 146S particles for foot-and-mouth disease vaccine production. Kim H; Kim AY; Kim JS; Lee JM; Kwon M; Bae S; Kim B; Park JW; Park CK; Ko YJ J Virol Methods; 2019 Jul; 269():26-29. PubMed ID: 30974178 [TBL] [Abstract][Full Text] [Related]
2. Application of Heparin Affinity Chromatography to Produce a Differential Vaccine without Eliciting Antibodies against the Nonstructural Proteins of the Serotype O Foot-and-Mouth Disease Viruses. Park SY; Lee JM; Kim AY; Park SH; Kim JS; Kim H; Park JW; Park JH; Ko YJ; Park CK Viruses; 2020 Dec; 12(12):. PubMed ID: 33297420 [TBL] [Abstract][Full Text] [Related]
3. Effect of thiomersal on dissociation of intact (146S) foot-and-mouth disease virions into 12S particles as assessed by novel ELISAs specific for either 146S or 12S particles. Harmsen MM; Fijten HP; Westra DF; Coco-Martin JM Vaccine; 2011 Mar; 29(15):2682-90. PubMed ID: 21316500 [TBL] [Abstract][Full Text] [Related]
4. Comparison of chemical extraction methods for determination of 146S content in foot-and-mouth disease oil-adjuvanted vaccine. Saravanan P; Iqbal Z; Selvaraj DPR; Aparna M; Umapathi V; Krishnaswamy N; Tamilselvan RP J Appl Microbiol; 2020 Jan; 128(1):65-73. PubMed ID: 31562676 [TBL] [Abstract][Full Text] [Related]
5. Quantitative Detection of the Foot-And-Mouth Disease Virus Serotype O 146S Antigen for Vaccine Production Using a Double-Antibody Sandwich ELISA and Nonlinear Standard Curves. Feng X; Ma JW; Sun SQ; Guo HC; Yang YM; Jin Y; Zhou GQ; He JJ; Guo JH; Qi SY; Lin M; Cai H; Liu XT PLoS One; 2016; 11(3):e0149569. PubMed ID: 26930597 [TBL] [Abstract][Full Text] [Related]
6. [Using size-exclusion chromatography to quantify the 146S antigen in inactivated foot-and-mouth disease vaccine]. Xu Y; Zou X; Li C; Zhu Y; He T; Yang Y; Lin X; Song Y; Zheng J; Zhang S; Zhao Q Sheng Wu Gong Cheng Xue Bao; 2018 May; 34(5):676-684. PubMed ID: 29893075 [TBL] [Abstract][Full Text] [Related]
7. Development of GEM-PA-nanotrap for purification of foot-and-mouth disease virus. Cheng H; Chen J; Cai Z; Du L; Hou J; Qiao X; Zheng Q Vaccine; 2019 May; 37(24):3205-3213. PubMed ID: 31036456 [TBL] [Abstract][Full Text] [Related]
8. [Vaccine pretreatment for quantification of 146S antigen in foot-and-mouth disease vaccines by high performance size exclusion chromatography]. Song Y; Yang Y; Su Z; Liu L; Zhu Y; Xu Y; Zou X; Zhao Q; Zhang S Sheng Wu Gong Cheng Xue Bao; 2019 Aug; 35(8):1441-1452. PubMed ID: 31441615 [TBL] [Abstract][Full Text] [Related]
10. Genetic and antigenic relationship of foot-and-mouth disease virus serotype O isolates with the vaccine strain O1/BFS. Xu W; Zhang Z; Nfon C; Yang M Vaccine; 2018 Jun; 36(26):3802-3808. PubMed ID: 29776753 [TBL] [Abstract][Full Text] [Related]
11. Effect of cell density on the biological titer and yield of 146S fraction of foot-and-mouth disease virus O in cell suspension. Rizvi A; Hussain N; Anjum AA; Ahmed N; Naeem A; Khan M; Altaf I J Virol Methods; 2022 Feb; 300():114379. PubMed ID: 34826516 [TBL] [Abstract][Full Text] [Related]
12. Detection of foot-and-mouth disease virus infection in vaccinated cattle. Niedbalski W Pol J Vet Sci; 2005; 8(4):283-7. PubMed ID: 16385852 [TBL] [Abstract][Full Text] [Related]
14. Investigation of the optimal medium and application strategy for foot-and-mouth disease vaccine antigen production. Kim AY; Kim H; Park SY; Park SH; Lee JM; Kim JS; Park JW; Park CK; Park JH; Ko YJ J Appl Microbiol; 2021 Sep; 131(3):1113-1122. PubMed ID: 33544957 [TBL] [Abstract][Full Text] [Related]
15. Isolation of Single-Domain Antibody Fragments That Preferentially Detect Intact (146S) Particles of Foot-and-Mouth Disease Virus for Use in Vaccine Quality Control. Harmsen MM; Seago J; Perez E; Charleston B; Eblé PL; Dekker A Front Immunol; 2017; 8():960. PubMed ID: 28861080 [TBL] [Abstract][Full Text] [Related]
16. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle. Sreenivasa BP; Mohapatra JK; Pauszek SJ; Koster M; Dhanya VC; Tamil Selvan RP; Hosamani M; Saravanan P; Basagoudanavar SH; de Los Santos T; Venkataramanan R; Rodriguez LL; Grubman MJ Vet Microbiol; 2017 May; 203():196-201. PubMed ID: 28619144 [TBL] [Abstract][Full Text] [Related]
17. Stabilizing effects of excipients on dissociation of intact (146S) foot-and-mouth disease virions into 12S particles during storage as oil-emulsion vaccine. Harmsen MM; Fijten HP; Westra DF; Dekker A Vaccine; 2015 May; 33(21):2477-84. PubMed ID: 25843267 [TBL] [Abstract][Full Text] [Related]
18. Foot-and-Mouth Disease (FMD) Virus 3C Protease Mutant L127P: Implications for FMD Vaccine Development. Puckette M; Clark BA; Smith JD; Turecek T; Martel E; Gabbert L; Pisano M; Hurtle W; Pacheco JM; Barrera J; Neilan JG; Rasmussen M J Virol; 2017 Nov; 91(22):. PubMed ID: 28878081 [TBL] [Abstract][Full Text] [Related]
19. Xylaria hypoxylon Lectin as Adjuvant Elicited Tfh Cell Responses. Kang J; Zuo Y; Guo Q; Wang H; Liu Q; Liu Q; Xia G; Kang Y Scand J Immunol; 2015 Nov; 82(5):436-42. PubMed ID: 26289530 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of novel inactivated vaccine for type C foot-and-mouth disease in cattle and pigs. You SH; Jo HE; Choi JH; Ko MK; Shin SH; Lee MJ; Kim SM; Kim B; Park JH Vet Microbiol; 2019 Jul; 234():44-50. PubMed ID: 31213271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]